Overview

Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States

Status:
Not yet recruiting

Trial end date:
2024-03-29

Target enrollment:

Participant gender:

Summary

To asses effectiveness and safety of tezepelumab in adult and adolescent participants with severe asthma including several under-studied populations in the United States.

Phase:

Phase 4

Details

Lead Sponsor:

AstraZeneca

Collaborator:

Parexel